A hierarchical deep-learning framework classified five lung and colon tissue classes with 98.50% accuracy on LC25000 and ...
Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths—around 1.8 million lives lost each year. One of the main reasons is late ...
InvestorsHub on MSN
BioAffinity Technologies receives Japanese patent allowance for CyPath Lung AI diagnostic test
The Japanese Patent Office has signalled its intention to grant patent protection for bioAffinity Technologies’ noninvasive lung cancer detection technology, expanding the company’s intellectual ...
Affinity Technologies receives Japanese patent for CyPath Lung test to detect lung cancer early: San Antonio Saturday, October 10, 2026, 13:00 Hrs [IST] bioAffinity Technologie ...
Lung cancer remains one of the malignancies with the highest incidence and mortality worldwide. Clinical practice has long been plagued by core dilemmas, including insufficient sensitivity in early ...
Grade 9 learner Brandon Mashandudze received top honours from Harvard Medical School’s Dr Chi-Fu Jeffrey Yang and the ...
SAN ANTONIO, October 08, 2026--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage ...
Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results